[CRVS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 0.60%
YoY- 20.72%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,816 -14,831 -8,363 -8,297 -9,236 -10,673 -11,752 -11.27%
Tax 6,384 -225 -100 884 8 -1,604 -1 -
NP -16,200 -14,831 -8,263 -9,181 -9,236 -10,673 -11,752 23.78%
Tax Rate - - - - - - - -
Total Cost 16,200 14,831 8,263 9,181 9,236 10,673 11,752 23.78%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.35 -0.32 -0.18 -0.20 -0.20 -0.24 -0.28 15.99%
EPS Diluted -0.35 -0.32 -0.18 -0.20 -0.20 -0.24 -0.28 15.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.